SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-10-022109
Filing Date
2010-04-27
Accepted
2010-04-27 16:04:41
Documents
6
Period of Report
2010-04-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a10-8827_18k.htm 8-K 41360
2 EX-99.1 a10-8827_1ex99d1.htm EX-99.1 107052
3 EX-99.2 a10-8827_1ex99d2.htm EX-99.2 12236
4 GRAPHIC g88271moi001.jpg GRAPHIC 3142
5 GRAPHIC g88271moi002.gif GRAPHIC 73
6 GRAPHIC g88271mmi001.jpg GRAPHIC 3090
  Complete submission text file 0001104659-10-022109.txt   171552
Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02140
Business Address 100 HAYDEN AVENUE LEXINGTON MA 02140 6174972070
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10865 | Film No.: 10773510
SIC: 2835 In Vitro & In Vivo Diagnostic Substances